TREM1 and cancer: Other pathways that showed altered activation status after C1QTNF6 knockdown, including TREM1 signaling, IL-6 signaling, and Toll-like Receptor signaling, can induce tumor cell apoptosis or activate anti-tumor immune responses, suggesting that they might be involved in the development of variant cancers [24–26].